Latest Breaking News On - Trishula therapeutics - Page 2 : comparemela.com

Ambagon Therapeutics Raises $85M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesSan carlosSan franciscoMichelle arkinChristian ottmannNancy pryerScott clarkeLuc brunsveldEindhoven university of technologyDirector of the small molecule discovery centerMission biocapitalVentures fundAmbagon therapeuticsNextech investDroia venturesInkef capital

Ambagon Therapeutics Launches With $85 Million Series A to Advance Pioneering Molecular Glue Platfor

Modular platform enables development of molecular glue stabilizers addressing intrinsically disordered proteins, a largely undrugged target classInitial discovery pipeline focused on high-value targets in oncologySAN FRANCISCO (BUSINESS WIRE) Ambagon Therapeutics, a biotechnology company unlocking intrinsically di.

United statesSan carlosMatt crensonNancy pryerScott clarkeMelissa mccrackenMichelle arkinAdam rosenbergChristian ottmannLuc brunsveldDirector of the small molecule discovery centerEindhoven university of technologyMission biocapitalVentures fundAmbagon therapeuticsDroia ventures

Ambagon Therapeutics Launches With $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline

Modular platform enables development of molecular glue stabilizers addressing intrinsically disordered proteins, a largely undrugged target class Initial discovery pipeline focused on high-value

United statesSan carlosMatt crensonNancy pryerScott clarkeMelissa mccrackenMichelle arkinKostenloser wertpapierhandelAdam rosenbergChristian ottmannLuc brunsveldDirector of the small molecule discovery centerEindhoven university of technologyMission biocapitalVentures fundDroia ventures

Curis Appoints John A Hohneker, M D To Board Of Directors

/PRNewswire/ Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today.

Evelo biosciencesBurroughs wellcomeJohna hohnekerJames dentzerGettysburg collegeCuris incTherapeutics incUniversity of north carolina at chapel hillHumanigen incBiotheryx incHealth sciencesGlobal head of developmentRutgers school of biomedicalDrug administrationAravive incTrishula therapeutics inc

Humanigen Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors

Humanigen Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesKevin xieKen trbovichBurroughs wellcomeCameron durrantJohn hohnekerGettysburg collegeUniversity of north carolina at chapel hillHumanigen incHealthcare holdings for fosun groupBiotheryx incGlobal head of developmentTianjin universityUniversity of medicineAravive inc